Search results
certain time point beyond diagnosis, for example, 5-year survival rate is the percentage of women alive 5 years after their diagnosis. 5-year conditional survival - the proportion of those alive who survived the first year, and subsequently went on to survive five years.
- WORLD OVARIAN CANCER COALITION ATLAS 2020
This paper explores ovarian cancer in the context of the...
- THE WORLD OVARIAN CANCER COALITION ATLAS
GLOBAL TRENDS IN INCIDENCE, MORTALITY AND SURVIVAL. April...
- WORLD OVARIAN CANCER COALITION ATLAS 2020
The earlier ovarian cancer is caught, the better chance a person has of surviving five years after being diagnosed. For ovarian cancer, 19.0% are diagnosed at the local stage. The 5-year relative survival for localized ovarian cancer is 91.9%.
Learn how likely it is that people with ovarian or fallopian tube cancer will live for 5 years after diagnosis, based on how far the cancer has spread. See the 5-year relative survival rates for different types and stages of ovarian cancer, and how they are calculated and interpreted.
This paper explores ovarian cancer in the context of the global cancer burden. The most recent estimates of incidence, mortality, and the numbers of women living with the disease are given together with projections for the year 2040.
There were more than 324,603 new cases of ovarian cancer in 2022. The 10 countries with the highest rates of ovarian cancer and the highest number of deaths from ovarian cancer in 2022 are shown in the tables below.
GLOBAL TRENDS IN INCIDENCE, MORTALITY AND SURVIVAL. April 2018. This report has been produced and funded by the World Ovarian Cancer Coalition. World Ovarian Cancer Coalition 2018. Study Director: Frances Reid Expert Advisory Panel Co-Chairs: Professor Neerja Bhatla and Annwen Jones. TABLE OF CONTENTS.
Results. During 17.7 years’ average follow-up, 13,222 women were diagnosed with ovarian cancer, and 8697 of them died from the disease. Stage at diagnosis was a major determinant of survival (stage IV vs I, RR=10.54, 95% CI: 9.16–12.13).